The Company is a biotechnology company engaged in the development, manufacture and sale of enzymes, other proteins, peptides and other bio-molecules derived from genes, and the collaborative licensing of its enabling proprietary technologies.
The best Bull and Bear pitches based on recency and number of recommendations.
This company needs to get to breakeven ahead of schedule, and I think that the market's optimism for DIL will wane in 07, which is why I'm putting an 'underperform' on it. 2006 saw the stock move from $2 to as high as $8. It's now hovering around $6… More
Read the most recent pitches from players about DYAI.DL.
Find the members with the highest scoring picks in DYAI.DL.
See what the Wall Street professionals think, according to their public statements and filings.